Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

NT-3 shows potential in diabetic neuropathy

April 12, 1996

Selective protein kinase C beta antagonist discovered by Lilly

April 12, 1996

New thiazolidinedione, MCC-555, reported by Mitsubishi Chemical

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

YM-087 in phase I for CHF

April 12, 1996

BDNF, CNTF protect against metabolic stress in vitro

April 12, 1996

Lubeluzole + DCLHb potentially effective in stroke

April 12, 1996

COX-2 inhibitor reported by Searle

April 12, 1996

T cell receptor vaccine effective in MS

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...